Cognex Corp: Form 10-Q for the period ended Mar 30, 2025
Filed with the SEC on May 1, 2025 and accepted by EDGAR at May 1, 2025, 06:23 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2025-03-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2025-01-01 to 2025-03-30 | $216.0m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months2025-01-01 to 2025-03-30 | $71.7m | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months2025-01-01 to 2025-03-30 | $144.3m | us-gaap:GrossProfit |
| Research and development | 3 months2025-01-01 to 2025-03-30 | $34.7m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months2025-01-01 to 2025-03-30 | $83.5m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2025-01-01 to 2025-03-30 | $26.1m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months2025-01-01 to 2025-03-30 | $4.2m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2025-01-01 to 2025-03-30 | $23.6m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2025-01-01 to 2025-03-30 | $0.14 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2025-01-01 to 2025-03-30 | $0.14 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2025-01-01 to 2025-03-30 | 170,391,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 3 months2025-01-01 to 2025-03-30 | $40.5m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 3 months2025-01-01 to 2025-03-30 | $2.5m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 3 months2025-01-01 to 2025-03-30 | $13.6m | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 3 months2025-01-01 to 2025-03-30 | $102.2m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2025-03-30 | $143.7m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2025-03-30 | $577.7m | us-gaap:AssetsCurrent |
| Total assets | At period end2025-03-30 | $1.93bn | us-gaap:Assets |
| Current liabilities | At period end2025-03-30 | $184.0m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2025-03-30 | $486.9m | us-gaap:Liabilities |
| Shareholders' equity | At period end2025-03-30 | $1.45bn | us-gaap:StockholdersEquity |
| Shares outstanding | At period end2025-03-30 | 167,864,778 shares | dei:EntityCommonStockSharesOutstanding |
Source: SEC EDGAR, the filing index for accession 0000851205-25-000031. Last ingested by Listed: Nov 5, 2026, 11:36 ET. Listed shows no prices and gives no investment advice.